ANI PHARMACEUTICALS, INC
Net Cash Flow Breakdown
Total Cash from Operations: $210.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $13.8M | 6.6% |
| Other Investing | $20.5M | 9.7% |
| Dividends Paid | $1.2M | 0.5% |
| Stock Repurchases | $12.2M | 5.8% |
| Working Capital | $22.5M | 10.7% |
| Net Cash Flow | $140.7M | 66.7% |